Study To Determine The Effects And Safety Of A Weight Loss Compound On Overweight, Otherwise Healthy, Volunteers

A 12-Week, Randomized, Subject And Investigator Blind, Placebo-Controlled Trial To Evaluate The Effect Of CP-866,087 On Weight Loss In Obese, Otherwise Healthy Adult Subjects

The purpose of this study is to determine whether CP-866,087 is effective in the weight loss of overweight patients.

Inclusion Criteria:

• Body Mass Index (BMI) 30 to 40 kg/m2 and total body weight of >110 lbs.
• Otherwise healthy

Exclusion Criteria:

• Women must be of non-childbearing potential.
• Significant current or history of medical illness.